UPDATE: April 29, 2021 – Second lot recalled due to presence of nitrosamine impurity Apotex Inc. is recalling a second lot of APO-Amitriptyline 10 mg tablets (lot PY1831, expiry 12/2023), after ...

Amitriptyline (Amitryn (10 mg)) is a tricyclic antidepressant, prescribed for depression. It is also prescribed for migraine and nerve pain. It corrects the imbalance of chemical substances acting on ...

GLASGOW, United Kingdom ― Amitriptyline, titrated at low dose, was superior to placebo as a second-line treatment for irritable bowel syndrome (IBS) across multiple outcomes in what the researchers ...

Amitriptyline can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research has found. The cheap and widely available prescription drug, which is commonly used at low ...

We conducted a randomized, double-blind, placebo-controlled trial of amitriptyline (1 mg per kilogram of body weight per day), topiramate (2 mg per kilogram per day), and placebo in children and ...

Titrated low-dose amitriptyline significantly improved irritable bowel syndrome (IBS) symptoms when used as a second-line treatment in the primary care setting, the randomized ATLANTIS trial showed.

Apotex Inc. is recalling one lot of APO-Amitriptyline 10 mg tablets after testing identified levels of N-nitrosodimethylamine (NDMA) above what is considered acceptable if the drug were to be taken ...

Apotex Inc. is recalling a second lot of APO-Amitriptyline 10 mg tablets (lot PY1831, expiry 12/2023), after testing identified NDMA, a nitrosamine impurity, above the acceptable limit. The affected ...